The co-primary endpoints were the percentage change of weight reduction in the Tirzepatide 10mg and 15mg dose groups at week 72 and the percentage of participants achieving 5% body weight reduction at 72 weeks compared to placebo
It adds that manufacturers routinely file additional patents covering new formulations, delivery systems, or uses, which prolongs exclusivity well past the original expiry date
However, any supplements, medications, or foods that cause stomach distress might increase gastrointestinal adverse effects
Semaglutide activates GLP-1 receptors in the brain and gut, slowing gastric emptying and reducing appetitebut this same mechanism can trigger dizziness in up to 25% of users during the first weeks of treatment
Doroszewska K, Milewicz T, Mroziska S, Janeczko J, Rokicki R, Janeczko M, Warzecha D, Marianowski P (2019) Blood pressure in postmenopausal women with a history of polycystic ovary syndrome